Audit-based education to reduce suboptimal management of cholesterol in primary care: A before and after study

Journal of Public Health

Volumn 28, Issue 4, 2006, Pages 361-369

  De Lusignan, S ^a   Belsey, J ^a   Hague, N ^a   Dhoul, N ^a   Van Vlymen, J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cardiovascular diseases; Cholesterol; Computerized statins; Family practices; HMG CoA; Medical records system; Myocardial ischemia

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; FLUINDOSTATIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EDUCATION PROGRAM; FEMALE; GENERAL PRACTICE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INFANT; MALE; MEDICAL AUDIT; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; TIME FACTORS;

EID: 33845250258     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdl052     Document Type: Article

References (41)

1. Department of Health. National Service Framework: Coronary Heart Disease. London 2000. http://www.dh.gov.uk/assetRoot/04/05/75/19/04057519.pdf (11 July 2006, date last accessed).
2. Department of Health. NHS Confederation and British Medical Association. Quality and Outcomes Framework (QOF) Guidance and Evidence Base. http://www.dh.gov.uk/assetRoot/04/08/86/93/04088693.pdf (11 July 2006, date last accessed).
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
4. Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
5. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1995;339:1349-57.
6. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
7. LaRosa JC, Grundy SM, Waters DD et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35.
8. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003;326:1423-7.
9. Edwards JE, Moore RA. Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials. BMC Fam Pract 2003;4:18-37.
10. Bedi A, Flaker GC. How do HMG-CoA reductase inhibitors prevent stroke? Am J Cardiovasc Drugs 2002;2:7-14.
11. Amarenco P, Lavallee P, Touboul PJ. Statins and stroke prevention. Cerebrovasc Dis 2004;17:81-8.
12. Briel M, Studer M, Glass TR et al. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2004;117:596-606.
13. Kim CK, Schmalfuss CM, Schofield RS et al. Pharmacological treatment of patients with peripheral arterial disease. Drugs 2003;63:637-47.
14. Hippisley-Cox J, Pringle M, Cater R et al. Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD. Br J Gen Pract 2005;55:369-75.
15. Reid FD, Cook DG, Whincup PH. Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart 2002;88:15-9.
16. DeWilde S, Carey IM, Bremner SA et al. Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart 2003;89:417-21.
17. de Lusignan S, Dzregah B, Hague N et al. Cholesterol management in patients with ischaemic heart disease: an audit-based appraisal of progress towards clinical targets in primary care. Br J Cardiol 2003;10:223-8.
18. de Lusignan S, Hague N, Brown A et al. An educational intervention to improve data recording in the management of ischaemic heart disease in primary care. J Public Health 2004;28:34-7.
19. St. George's - University of London. PCDQ (Primary Care Data Quality) Programme. What is MIQUEST? http://www.pcdq.org/miquest.htm (11 July 2006, date last accessed).
20. de Lusignan S. Using the feedback of routinely collected computer data to improve the quality of chronic disease management in UK primary care. Acta Informatica Medica 2005;13:59-63.
21. Faulconer E, de Lusignan S. An eight-step method for assessing diagnostic data quality in practice: chronic obstructive pulmonary disease as an exemplar. Inform Prim Care 2004;12:243-54.
22. van Vlymen J, de Lusignan S, Hague N et al. Ensuring the quality of aggregated general practice data: lessons from the Primary Care Data Quality Programme (PCDQ). Stud Health Technol Inform 2005;116:1010-15.
23. Berndt DJ, Fisher JW, Hevner AR et al. Healthcare data warehousing and quality assurance. IEEE Computer 2001;34:56-65.
24. NHS Public Health Network. Directly Age-Standardised Rates. http://www.avon.nhs.uk/phnet/methods/directly_age_standardised_rates.htm (17 June 2005, date last accessed).
25. National Statistics.Population Trends. 2003;113 (Autumn):45 (Table 1.4). http://www.statistics.gov.uk/downloads/theme_population/PT113.pdf (11 July 2006, date last accessed).
26. North Carolina State University. Logistic Regression. http://www2.chass.ncsu.edu/garson/pa765/logistic.htm (11 July 2006, date last accessed).
27. Department of Health. Prevalence Recorded for Diseases in the New GMS Contract for 2004/5. http://www.gponline.com/attachments/pdfs/UKprevalence.pdf (17 June 2005, date last accessed).
28. Williams P, de Lusignan S. Does a higher 'quality points' score mean better care in stroke? An audit of general practice medical records. Inform Prim Care 2006;14:29-40.
29. Baessler A, Fischer M, Huf V et al. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates. Int J Cardiol 2005;101:293-8.
30. Rudd AG, Lowe D, Hoffman A et al. Secondary prevention for stroke in the United Kingdom: results from the National Sentinel Audit of Stroke. Age Ageing 2004;33:280-6.
31. Mantel-Teeuwisse AK, Klungel OH, Schalekamp T et al. Suboptimal choices and dosing of statins at start of therapy. Br J Clin Pharmacol 2005;60:83-9.
32. Bazalo GR. Managed care trends in statin usage. Manag Care 2001;10:48-59.
33. Pitt B. Low-density lipoprotein cholesterol in patients with stable coronary heart disease - is it time to shift our goals? N Engl J Med 2005;352:1483-4.
34. Toal M, Walker R. Angiotensin converting enzyme (ACE) inhibitors in the treatment of heart failure in general practice in north Cumbria. Eur J Heart Fail 2000;2:201-7.
35. Porcu M, Opasich C, Scherillo M et al. Improving practice patterns in heart failure through a national cardiological network: the case of ACE-inhibitors. Ital Heart J 2002;3:730-7.
36. Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623-30.
37. Vrecer M, Turk S, Drinovec J et al. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. Int J Clin Pharmacol Ther 2003;41:567-77.
38. Allen Maycock CA, Muhlestein JB, Horne BD et al. Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol 2002;40:1777-85.
39. Thiru K, De Lusignan S, Sullivan F et al. Three steps to data quality. Inform Prim Care 2003;11:95-102.
40. Thiru K, Hassey A, Sullivan F. Systematic review of scope and quality of electronic patient record data in primary care. BMJ 2003;326:1070-5.
41. Gray J, Majeed A, Kerry S et al. Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records. BMJ 2000;321:548-50.